Altaris to Acquire Simulations Plus for $375M

Simulations Plus (SLP [https://seekingalpha.com/symbol/SLP]) has entered into a definitive agreement to be acquired by affiliates of Altaris for $375 in an all-cash transaction.

Under the terms of the agreement, Simulations Plus common stockholders will receive $18.50 per share, representing a premium of 26% to its 60-day volume-weighted average price as of June 15, 2026.

Simulations is expected to be combined with Chemical Computing Group, an existing Altaris portfolio company that provides advanced molecular design software to customers across the pharmaceutical, chemical, and materials sectors.

Upon closing of the deal, Simulations Plus will become a privately held subsidiary of Altaris, and its common stock will no longer be traded on the Nasdaq.

Source: Press Release [https://seekingalpha.com/pr/20553130-simulations-plus-to-be-acquired-by-altaris-for-approximately-375-million]

MORE ON SIMULATIONS PLUS

* Simulations Plus: Better Quarter, Same Doubts [https://seekingalpha.com/article/4890948-simulations-plus-better-quarter-same-doubts]
* Simulations Plus: Down Substantially, Not An Automatic Buy [https://seekingalpha.com/article/4890060-simulations-plus-down-substantially-not-automatic-buy]
* Simulations Plus, Inc. (SLP) Q2 2026 Earnings Call Transcript [https://seekingalpha.com/article/4889669-simulations-plus-inc-slp-q2-2026-earnings-call-transcript]
* Simulations Plus jumps on earnings beat, sees AI boosting biosimulation outlook [https://seekingalpha.com/news/4573959-simulations-plus-jumps-on-earnings-beat-sees-ai-boosting-biosimulation-outlook]
* Simulations Plus Q2 2026 Earnings Preview [https://seekingalpha.com/news/4573380-simulations-plus-q2-2026-earnings-preview]